UniQure files Form 144 to sell 30,000 shares

Uniqure N.V. filed a Form 144 reporting proposed sales and recent dispositions of its Ordinary Shares.

Rhea-AI Filing Summary

Uniqure N.V. filed a Form 144 reporting proposed sales and recent dispositions of its Ordinary Shares. The filing lists a proposed sale of 30,000 Ordinary Shares through Citigroup Global Markets, Inc., dated 06/30/2026. It also records a 10,000-share option exercise under a Rule 10b5-1 plan on 06/30/2026 and 20,000 vested restricted shares on 06/26/2025. The filing shows past sales in the three months including 45,000 shares sold on 05/08/2026 for $1,127,435.50 and 1,434 shares sold on 06/26/2026 for $67,197.10.

Insights

Securities Attorney

Form 144 lists resale activity and planned brokered sales; compliance and timing matter.

Form 144 is a notice of proposed sale by affiliates; this filing lists a 30,000-share offering through Citigroup Global Markets, Inc. dated 06/30/2026. The presence of a 10b5-1 plan exercise is noted for 10,000 shares.

Key legal dependencies are the brokered sale mechanics and Rule 144 holding requirements where applicable. Subsequent sale settlement and any required public disclosures will appear in follow-on filings.

Key Figures

Proposed sale: 30,000 shares Option exercise (10b5-1): 10,000 shares Vested restricted shares: 20,000 shares +2 more

5 metrics

Proposed sale 30,000 shares Sale through Citigroup Global Markets, Inc., <date>06/30/2026</date>

Option exercise (10b5-1) 10,000 shares Exercise pursuant to a Rule 10b5-1 plan on <date>06/30/2026</date>

Vested restricted shares 20,000 shares Vesting recorded on <date>06/26/2025</date>

Sale on 05/08/2026 45,000 shares Proceeds $1,127,435.50 on <date>05/08/2026</date>

Sale on 06/26/2026 1,434 shares Proceeds $67,197.10 on <date>06/26/2026</date>

Key Terms

Rule 10b5-1, Form 144, restricted stock vesting

3 terms

Rule 10b5-1 regulatory

"Stock option exercise pursuant to 10b51 plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock vesting financial

"Vested shares resulting from restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UniQure (QURE) report in this Form 144?

The Form 144 reports a proposed sale of 30,000 Ordinary Shares through Citigroup Global Markets, Inc. on 06/30/2026, plus recent exercises and vesting that created saleable shares.

Were there recent insider exercises or vesting for UniQure (QURE)?

Yes. The filing shows a 10,000-share option exercise pursuant to a Rule 10b5-1 plan on 06/30/2026 and 20,000 shares from restricted stock vesting on 06/26/2025.

What recent sales does the Form 144 disclose for UniQure (QURE)?

The filing discloses sales in the past three months including 45,000 shares sold on 05/08/2026 for $1,127,435.50 and 1,434 shares sold on 06/26/2026 for $67,197.10.

Who is the broker listed for the proposed sale in the Form 144?

The proposed sale of 30,000 Ordinary Shares is listed with Citigroup Global Markets, Inc., 390 Greenwich St, New York, NY with an effective date of 06/30/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/30/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001985973
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	uniQure N.V.
SEC File Number	001-36294
Address of Issuer	PAASHEUVELWEG 25A AMSTERDAM NETHERLANDS 1105 BP
Phone	1-339-970-7000
Name of Person for Whose Account the Securities are To Be Sold	Abi-Saab Walid
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Medical Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich St New York NY 10013	30000	1392643.00	63067485	06/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	06/30/2026	Stock option exercise pursuant to 10b51 plan	Uniqure N.V.			10000	06/30/2026	Cash
ORDINARY SHARES	06/26/2025	Vested shares resulting from restricted Stock Vesting	Uniqure N.V			20000	06/30/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Abi-Saab Walid PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP	Ordinary Shares	05/08/2026	45000	1127435.50
Abi-Saab Walid PAASHEUVELWEG 25A AMSTERDAM P7 1105BP	Ordinary shares	06/26/2026	1434	67197.10

144: Remarks and Signature

Remarks	Shares were sold pursuant to 10b51 plan adopted in September 2025
Date of Notice	06/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Conformed Signature On File
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)